Open Government Portal

A national summary of what is currently known about the Canadian opioid crisis with respect to opioid-related deaths and harms and potential risk factors as of December 2017.

opioid- and other drug-related overdose deaths have increased sharply and become a significant cause of mortality in Canada. In response, local governments, provinces, and territories have implemented a variety of interventions and the Government of Canada has committed to a targeted public health response

Data from surveillance reports provide information on opioid- and stimulant-related harms (deaths, hospitalizations, and responses by emergency medical services) in Canada.

The Public Health Agency of Canada (PHAC) works closely with the provinces and territories to collect and share accurate information about the overdose crisis in order to provide a national picture of the public health impact of opioids and other drugs in Canada and to help guide efforts to reduce substance-related harms.

This article highlights initiatives undertaken by federal partners to address the opioid crisis in Canada. The need for novel surveillance approaches that improve the collection and harmonization of drug-related data is also discussed.

The COVID-19 pandemic is adding to the ongoing public health crisis related to high rates of opioid overdose and deaths, as well as acute substance use harms. These crises are made worse in communities where there is chronic overcrowding, including a shortage of housing or other shelters.

The COVID-19 pandemic is adding to the ongoing public health crisis related to high rates of opioid overdose and deaths, as well as acute substance use harms. These crises are made worse in communities where there is chronic overcrowding, including a shortage of housing or other shelters.

Policies related to the Death Benefit.

This table contains 11 series, with data for years 1968 - 2009 (not all combinations necessarily have data for all years), and was last released on 2010-08-30. This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Type of benefit and policy (11 items: Total; payments; Death and accidental death claims; Total; under life insurance; Disability benefits; income payments ...).

Age-Sex Specific rates for persons who filled at least one prescription of antidepressant or
antianxiety/ opioids medications by Anatomical Therapeutic Chemical name from community pharmacies for Alberta, nine health regions, and five Alberta Health Services (AHS) Continuum Zones expressed as per 1000 population.

Number of deaths occurring in the province of Alberta, by year, gender, age, and cause of death.